Huimei Capital
Overview
Huimei Capital is an early and growth stage venture capital firm that focuses on investing in the healthcare sector . It was co-founded by Hillhouse Capital and Mayo Clinic . The firm is committed to building an investment platform with a global view and local execution to help early and growth-stage healthcare companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanovision Technology | Dec 2019 | Series C | Co-investor |
| Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd. | Aug 2022 | Series B | Co-investor |
| Wuhan YZY Medical Science and Technology Co., Ltd. | Aug 2021 | Series B Extension | Co-investor |
| Huimei Technology | Aug 2019 | Series C | Co-investor |
| Shanghai LePure Biotechnology Co., Ltd. | Jan 2023 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Huimei Capital based?
Huimei Capital is headquartered in Beijing, Beijing, China.
When was Huimei Capital founded?
Huimei Capital was founded in 2018.
How many portfolio companies does Huimei Capital have?
Huimei Capital has 16 portfolio companies in Caplight's dataset.
What are some companies in Huimei Capital's portfolio?
Portfolio companies visible on Caplight include Nanovision Technology, Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd., Wuhan YZY Medical Science and Technology Co., Ltd., Huimei Technology, Shanghai LePure Biotechnology Co., Ltd..
What was Huimei Capital's most recent investment shown here?
Huimei Capital's most recent investment in this portfolio sample was in Shanghai LePure Biotechnology Co., Ltd. in 2023.
What sectors does Huimei Capital focus on?
Huimei Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Huimei Capital focus on?
Huimei Capital typically invests at the Mid stage.
What is Huimei Capital's AUM?
Huimei Capital's assets under management are estimated between $100.0M and $250.0M.